Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Solid Organ Transplant
100%
Cancer Incidence
100%
Immunocompromised Patients
100%
Multicenter Cohort Study
100%
Tumor Necrosis Factor Inhibitor (TNFi)
100%
Cancer Risk
71%
Hematopoietic Stem Cell Transplant
71%
Inhibitor Therapy
28%
Cancer Screening
28%
Cancer Development
28%
Hematopoietic Stem Cell Transplant Recipients
28%
Health Systems
14%
Hypertension
14%
Cardiovascular Disease
14%
Primary Immunodeficiency
14%
End-stage Renal Disease
14%
Race-ethnicity
14%
Selection Strategy
14%
Retrospective Cohort Study
14%
Significant Risk Factors
14%
Tumor Registry
14%
Multivariable Model
14%
Charlson Comorbidity Index
14%
Cox Proportional Hazards Model
14%
White Patients
14%
Male Gender
14%
Medication Orders
14%
Cancer Institute
14%
Immune Defense
14%
Kaplan-Meier Method
14%
Age 50
14%
Role in Cancer
14%
Renal Cyst
14%
University of Utah
14%
Secondary Immunodeficiency
14%
Stepwise Variable Selection
14%
New Primary Cancer
14%
Adjusted Hazard Ratio
14%
System Database
14%
Clinical Comorbidities
14%
Independent Risk Factors
14%
Onset Time
14%
In Situ Disease
14%
Medicine and Dentistry
Cohort Analysis
100%
Cancer Incidence
100%
Hematopoietic Stem Cell Transplantation
100%
TNF Inhibitor
100%
Immunocompromised Patient
100%
Malignant Neoplasm
57%
Immune Deficiency
28%
Cancer Screening
28%
Neoplasm
14%
Health System
14%
Cardiovascular Disease
14%
Retrospective Cohort Study
14%
Primary Tumor
14%
End Stage Renal Disease
14%
Charlson Comorbidity Index
14%
Proportional Hazards Model
14%
Hazard Ratio
14%
Kaplan Meier Method
14%
Immunodeficiency
14%
Renal Cyst
14%
Comorbidity
14%
Diseases
14%
Hypertension
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
100%
Cancer Incidence
100%
Tumor Necrosis Factor Inhibitor
100%
Immunocompromised Patient
100%
Malignant Neoplasm
85%
Immune Deficiency
28%
Comorbidity
28%
Diseases
28%
End Stage Renal Disease
14%
Kidney Cyst
14%
Neoplasm
14%
Primary Tumor
14%
Cardiovascular Disease
14%
Hypertension
14%
Immunology and Microbiology
Cancer Incidence
100%
TNF Inhibitor
100%
Immunocompromised Patient
100%
Hematopoietic Stem Cell Transplantation
100%
Immunodeficiency
28%
Comorbidity
28%
Cancer Screening
28%
Cardiovascular System
14%
Biochemistry, Genetics and Molecular Biology
Cohort Study
100%
Cancer Incidence
100%
Hematopoietic Stem Cell Transplantation
100%
TNF Inhibitor
100%
Comorbidity
28%
Cancer Screening
28%